IBRX FINAL DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys Before Aug. 29th Deadline in Securities Fraud Class Action
28 août 2023 13h31 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23, 2022...
IBRX CLASS ACTION REMINDER: Hagens Berman Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending
31 juil. 2023 11h36 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, July 31, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23, 2022...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Notifies ImmunityBio (IBRX) Investors of Application Deadline in Securities Fraud Class Action, Encourages Investors with Substantial Losses to Contact Firm’s Attorneys
24 juil. 2023 12h01 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, July 24, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23,...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed
17 juil. 2023 11h56 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, July 17, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23, 2022...
IBRX ALERT: Hagens Berman, National Trial Attorneys, Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed
02 juil. 2023 11h25 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, July 02, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23, 2022...
IBRX INVESTIGATION: Hagens Berman, National Trial Attorneys, Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations Regarding FDA Complete Response Letter
18 mai 2023 13h11 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, May 18, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Visit:...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations Regarding FDA Complete Response Letter
11 mai 2023 16h58 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, May 11, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Visit:...